Literature DB >> 681976

Protein fractions of lumbar, cisternal, and ventricular cerebrospinal fluid. Separate areas of reference.

B Weisner, W Bernhardt.   

Abstract

Ventricular (n=27), cisternal (n=33) and lumbar (n=127) cerebrospinal fluid of "non-diseased" reference persons was investigated. The following measurements were taken: (1) Total protein, albumin, immunoglobulin A,G, M (IgA,G,M) in unconcentrated cerebrospinal fluid (CSF). (2) Protein fractions in the microzone electrophoresis of concentrated CSF. Albumin and IgG concentrations were highly correlated in all the samples, regardless of their origin. Therefore, bivariate areas of reference as well as interdependent regression coefficients were computed for the paired data. The regression lines of the 3 different areas of reference (ventricular, cisternal, lumbar) ran parallel to each other, displaced along the axis of the IgG concentration: approximately 10% of the lumbar IgG does not originate directly from serum. Although the albumin concentration increased 2.2 times, and the IgG 2.6 times, from ventricular to lumbar region, the concentration of pre-albumin decreased by a factor of 0.7. The concentration of IgA never surpassed the limits of detection set by this method (8 mg/I), in spite of its similarity to IgG regarding molecular weight and size. The observations strengthen the assumption that selective functions are present at the blood-CSF barrier. In 4 illustrative cases with a chronic inflammatory process, the discriminating power of the different reference areas was demonstrated. The findings should be evaluated in a multivariate manner, considering the location from which the sample was obtained.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 681976     DOI: 10.1016/0022-510x(78)90204-6

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  25 in total

Review 1.  The choroid plexuses and the barriers between the blood and the cerebrospinal fluid.

Authors:  M B Segal
Journal:  Cell Mol Neurobiol       Date:  2000-04       Impact factor: 5.046

2.  Intravitreal, retinal, and central nervous system foscarnet concentrations after rapid intravenous administration to rabbits.

Authors:  L F López-Cortés; R Ruiz-Valderas; M J Lucero-Muñoz; E Cordero; M T Pastor-Ramos; J Marquez
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

3.  Antibody pharmacokinetics in rat brain determined using microdialysis.

Authors:  Hsueh-Yuan Chang; Kasey Morrow; Emily Bonacquisti; WanYing Zhang; Dhaval K Shah
Journal:  MAbs       Date:  2018-08-06       Impact factor: 5.857

4.  Blood-cerebrospinal fluid barrier in schizophrenic patients.

Authors:  K Bauer; J Kornhuber
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1987

5.  Overton's rule helps to estimate the penetration of anti-infectives into patients' cerebrospinal fluid.

Authors:  Marija Djukic; Martin Munz; Fritz Sörgel; Ulrike Holzgrabe; Helmut Eiffert; Roland Nau
Journal:  Antimicrob Agents Chemother       Date:  2011-11-21       Impact factor: 5.191

6.  Zinc concentrations in the cerebrospinal fluid of normal adults and patients with neurological diseases.

Authors:  R Palm; G Hallmans
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-08       Impact factor: 10.154

Review 7.  Proteomic analyses of CSF aimed at biomarker development for pediatric brain tumors.

Authors:  Nardin Samuel; Marc Remke; James T Rutka; Brian Raught; David Malkin
Journal:  J Neurooncol       Date:  2014-04-26       Impact factor: 4.130

8.  Communicating hydrocephalus and vestibular schwannomas: etiology, treatment, and long-term follow-up.

Authors:  Qasim Al Hinai; Anthony Zeitouni; Denis Sirhan; David Sinclair; Denis Melancon; John Richardson; Richard Leblanc
Journal:  J Neurol Surg B Skull Base       Date:  2013-02-07

9.  Selective Detection of the D-enantiomer of 2-Hydroxyglutarate in the CSF of Glioma Patients with Mutated Isocitrate Dehydrogenase.

Authors:  Juliya Kalinina; Jun Ahn; Narra S Devi; Liya Wang; Yuancheng Li; Jeffrey J Olson; Michael Glantz; Thomas Smith; Ella L Kim; Alf Giese; Randy L Jensen; Clark C Chen; Bob S Carter; Hui Mao; Miao He; Erwin G Van Meir
Journal:  Clin Cancer Res       Date:  2016-06-23       Impact factor: 12.531

Review 10.  Pharmacokinetic optimisation of the treatment of bacterial central nervous system infections.

Authors:  R Nau; F Sörgel; H W Prange
Journal:  Clin Pharmacokinet       Date:  1998-09       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.